|
Field
Abstract
|
Before
Abstract
The objective of this study was to investigate the effectiveness of Transdiagnostic Group Therapy on Women with Multiple Sclerosis.
Anxiety is highly comorbid with depression, but little is known about the impact of anxiety disorders on the effectiveness of empirically supported psychotherapies for depression. We examined such outcomes for people.The prevalence of both anxiety and depressive the group examined in this study, in which lifetime prevalence and MDD is around 50% . As in medically healthy people, the consequences of these disorders for people with MS include higher risk for suicide .
|
After
Abstract
The objective of this study was to investigate the effectiveness of The Application of shared Mechanism Therapies on Emotion in Patient With Chronic disease With Comorbidity
Anxiety is highly comorbid with depression, but little is known about the impact of anxiety disorders on the effectiveness of empirically supported psychotherapies for depression. We examined such outcomes for people.The prevalence of both anxiety and depressive the group examined in this study, in which lifetime prevalence and MDD is around 50% . As in medically healthy people, the consequences of these disorders for people with MS include higher risk for suicide .
|
|
Field
Last Published
|
Before
August 14, 2019 12:39 AM
|
After
August 14, 2019 12:43 AM
|
|
Field
Intervention (Public)
|
Before
The purpose of this study was to assess the efficacy of the unified protocol transdiagnostic cognitive behavior therapy (tCBT) as a treatment for multiple sclerosis (MS) fatigue. A randomized controlled design was used where 72 patients with MS fatigue were randomly assigned to 14 weekly sessions of tCBT . Participants were assessed before and after treatment, and at 3 months after post-treatment.
|
After
The purpose of this study was to assess the efficacy of the Application of shared Mechanism Therapies cognitive behavior therapy (CBT) as a treatment for multiple sclerosis (MS) fatigue on Emotion in Patient With Chronic disease With Comorbidity . A randomized controlled design was used where 72 patients with MS fatigue were randomly assigned to 14 weekly sessions of tCBT . Participants were assessed before and after treatment, and at 3 months after post-treatment.
|
|
Field
Experimental Design (Public)
|
Before
The inclusion criteria included:
1. Diagnosis of MS for three years or more
2. Fluent in Persian, at least 18 years of age
4. Meet scid
5. Received at least one self-report rch.
6. Fill and signature consent
7. Medical agreement for participation
Exclusion criteria included
1. The initial diagnosis of other psychiatric diagnoses, compensatory behaviors or cleansing,
2. Other Chronic physical illnesses (such as insulin-dependent diabetes and chemotherapy for cancer)
3. Pregnancy or lactation,
4. Evidence of current or past schizophrenia, psychosis, or organic mental disorder, bipolar disorder, or organic mental disorder
6. Drug abuse history or drug dependence except for nicotine
7. Absenteeism for more than three sessions
8. Receiving psychological interventions during one last year.
9. Presence of comorbid neurological disorders such as Alzheimer, Parkinson's disease, Dementia
|
After
The inclusion criteria included:
1. Diagnosis of MS at least 18 years of age
2. Fluent in Persian,
4. Meet scid
5. Received at least one self-report rch.
6. Fill and signature consent
7. Medical agreement for participation
Exclusion criteria included
1. The initial diagnosis of other psychiatric diagnoses, compensatory behaviors or cleansing,
2. Other Chronic physical illnesses (such as insulin-dependent diabetes and chemotherapy for cancer)
3. Pregnancy or breast feeding
4. Evidence of current or past schizophrenia, psychosis, or organic mental disorder, bipolar disorder, or organic mental disorder
6. Drug abuse history
7. Absenteeism
8. Receiving psychological interventions during one last year.
9. Presence of comorbid neurological disorders such as Alzheimer, Parkinson's disease, Dementia
|